The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2011Role of PARK18 in Parkinson's Disease
Objective/Rationale:
PARK18 is a genetic marker that was recently found to be associated with susceptibility to Parkinson’s disease (PD). The marker is encoded within the HLA-DRA gene, a gene that... -
MJFF Research Grant, 2011fMRI of First Degree Relatives of LRRK2 Positive PD Patients
Objective/Rationale:
First, to study the effect of the presence of the LRRK2 G2019S mutation on brain activation patterns in Parkinson’s disease (PD) patients who recently converted into a diseased...
-
Repositioning Drugs for PD, 2011Fasudil as a Novel Therapeutic for the Treatment of Parkinson's Disease
Objective/Rationale:
The therapeutic drug we will repurpose for Parkinson’s disease (PD) is fasudil, a kinase inhibitor with an impressive safety profile in humans. The target of fasudil is highly... -
Repositioning Drugs for PD, 2011DPP-4 Inhibitors for the Treatment of Parkinson's Disease
Objective/Rationale:
This is a collaborative research project between three organizations, NIDA, NIA and Pfizer, focused towards characterizing whether gliptins, a well-tolerated drug class effective... -
Repositioning Drugs for PD, 2011Repositioning BCG Vaccination as an Immunostimulant for Slowing the Progression of PD
Objective/Rationale:
We recently demonstrated that strong immune system stimulation created by treating pre-clinical models with a safe vaccine (called BCG) can have a restorative effect on... -
Clinical Intervention Awards, 2011NH004 Films for Sialorrhea in PD Patients (2011)
Objective/Rationale:
Uncontrolled saliva or drooling (sialorrhea) is a socially debilitating condition with high prevalence in Parkinson’s disease (PD) patients. The NH004 treatment to control...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.